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Abstract
Background Multidrug-resistant (MDR) bacteria are an emerging international concern in low- and middle-income
countries that threaten recent public health gains. These challenges are exacerbated in immunocompromised hosts,
such as those with burn injury. This study sought to describe the epidemiology and associated clinical outcomes of
burn wound colonization in a Malawian tertiary burn center.
Methods This is a prospective analysis of burn patients presenting to Kamuzu Central Hospital in Lilongwe, Malawi,
within 72 h of burn injury. A swab of each patient’s primary wound was collected at admission and each subsequent
week. The primary exposure was burn wound colonization with MDR bacteria, particularly Enterobacteriaceae. The
primary outcome was in-hospital mortality. A log binomial model estimated the association between the exposure
and outcome, adjusted for confounders.
Results Ninety-nine patients were enrolled with a median age of 4 years (IQR 2–12) and a male preponderance
(54%). Median total body surface area burn (TBSA) was 14% (IQR 9–25), and crude in-hospital mortality was 19%.
Enterobacteriaceae were the most common MDR bacteria with 36% of patients becoming colonized. Wound
colonization with MDR Enterobacteriaceae was associated with increased in-hospital mortality with a risk ratio of
1.86 (95% CI 1.38, 2.50, p\ 0.001) adjusted for TBSA, burn type (scald vs. flame), sex, age, length of stay, and
methicillin-resistant Staphylococcus aureus colonization.
Conclusion MDR bacteria, especially Enterobacteriaceae, are common and are associated with worse burn injury
outcomes. In resource-poor environments, a greater emphasis on prevention of MDR bacterial colonization,
improved isolation precautions, affordable diagnostics, and antibiotic stewardship are imperative.
Introduction
In an era of increasing global migration, bacterial infec-
tions and rising resistance to antimicrobial drugs represent
a substantial threat to global public health. Substantial
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a breakdown of the natural skin barrier to microbes, a
propensity to bacterial wound colonization, and thermal
injury-associated immunosuppression [10]. At facilities in
resource-poor countries, wound dressing management is
dependent on limited supplies and inconsistent staffing
often leading to wound infection and poor healing.
In the setting of emerging antibiotic resistance, we
sought to describe the epidemiology of burn wound colo-
nization in a Malawian tertiary burn center hypothesizing
that MDR bacteria would be associated with poorer out-
comes among burn patients.
Methods
We performed a prospective observational study of patients
admitted to Kamuzu Central Hospital (KCH) with acute
burn injury from May 2015 through November 2015. KCH
is a public 600-bed tertiary care hospital in the capital city
of Lilongwe, which serves as a referral center for approx-
imately 5 million people in the central region of Malawi.
All adult and pediatric patients in the study were admitted
to the KCH Burn Unit, which was established in 2011 and
averages 25–40 admissions per month [13]. The KCH Burn
unit is a 31-bed unit with 6 full-time nurses and 2 trained
clinical officer staff with surgical consultant oversight.
Ward dressing changes routinely occur on Monday, Wed-
nesday, and Friday each week in a room equipped with a
bathing tank and dressing supplies. Pain control during
wound changes is typically achieved with either with an
acetaminophen or ibuprofen equivalent, oral morphine
when available, or ketamine for large burns.
Pediatric and adult patients were included in the study if
they presented with an acute burn injury that required
admission, presented within 72 h of their initial injury, and
consented to participate in the study. Baseline demographic
and clinical data were obtained in addition to vital signs,
laboratory investigation results, admission diagnoses, tim-
ing of burn excision and grafting, and mortality (lived/
died).
Using BD CultureSwabsTM, wound cultures were
obtained at the patient’s first dressing change, which
occurred 24–48 h after admission. If the patient was still
admitted, a subsequent culture was obtained 1 week later
during their dressing change and then a third culture
another week later. Cultures were taken from the patient’s
deepest burns when possible. Nursing staff obtained the
cultures after being trained on appropriate technique. The
technique included sterilely swabbing the wound bed once
before application of the wound dressing. The culture
swabs were immediately hand-delivered to the UNC Pro-
ject Laboratory, located on the grounds of KCH, for
testing.
evidence exists that the prevalence of antibiotic resistance, 
even to last-line therapy, among many bacterial families is 
rapidly increasing [1, 2]. Many of these bacteria are com-
monly the source of hospital- and community-acquired 
infections and can lead to substantial morbidity and 
mortality.
Antimicrobial resistance is the consequence of a variety 
of biological, pharmacological, and societal variables that 
occur worldwide, particularly in low- and middle-income 
countries (LMICs) [3]. In addition, data suggest that 
antibiotic resistance is developing at a faster rate in LMICs 
compared to developed countries [4]. Health systems in 
poor countries often cannot offer the most optimal thera-
pies or the medical technology required to appropriately 
deliver such medicines. The lack of routine drug sensitivity 
testing and surveillance in many regions results in the 
irrational use of antibiotics and other antimicrobial drugs 
[5, 6]. Furthermore, the overuse of cheap, broad-spectrum 
antibiotics and poor control of over-the-counter sales have 
fostered widespread resistance. When therapeutic failure 
occurs, it often arises from misdiagnosis, drug resistance, 
or poor drug quality.
The World Health Organization (WHO) has recognized 
multidrug-resistant (MDR) bacteria as an emerging inter-
national concern that threatens the effective prevention and 
treatment of bacterial infections [7]. While the exact defi-
nition of multidrug resistance can vary, it is frequently used 
to indicate resistance to representatives of three or more 
classes of antimicrobial agents [8]. Countries in at least five 
of six WHO regions have reported greater than 50%
resistance to commonly used and available antibiotics for 
bacterial species such as Escherichia coli and Klebsiella 
pneumoniae, constraining clinicians in resource-poor 
environments to use scarce and expensive options such as 
carbapenems [3].
The problems of antimicrobial resistance faced in 
regions like sub-Saharan Africa are further exacerbated in 
immunocompromised hosts, such as those with burn injury. 
Globally, burn injuries are an important cause of morbidity 
and mortality in LMICs, ranking fourth in all causes of 
injuries [9]. Among burn patients, sepsis is the leading 
cause of death, in both developed and developing countries 
[10]. Many of the organisms commonly recovered from 
infected burn patients are members of the ESKAPE (En-
terococcus faecium, Staphylococcus aureus, Klebsiella 
pneumoniae, Acinetobacter baumannii, Pseudomonas 
aeruginosa, and Enterobacter species) group of pathogens, 
which are often resistant to several classes of antibiotics 
[11]. In particular, Enterobacteriaceae, a family of gram-
negative bacilli with many members of normal intestinal 
flora such Klebsiella and Enterobacter spp., are emerging 
as important pathogens among burn patients [12]. Burn 
patients are especially vulnerable to invasive infection with
The UNC Project Laboratory is a state-of-the-art clinical
and research laboratory, with the mission to support clin-
ical care, research, and training activities of the UNC
Project. This laboratory, with a dedicated team of 24 lab-
oratory professionals and 9 support staff, processes more
than 150,000 laboratory orders annually, performs exten-
sive quality control measures, and has been awarded 4 star
status by the African Society for Laboratory Medicine.
Initially, we conducted an exploratory analysis of our
exposure, defined as wound colonization with MDR bac-
teria. Colonization was defined as bacterial growth in at
least one culture. MDR was defined by the International
Expert Proposal for Interim Standard Definitions for
Acquired Resistance, which requires non-susceptibility to 3
or more specified categories of antimicrobials [14]. We
grouped bacteria into four categories: methicillin-resistant
Staphylococcus aureus (MRSA), vancomycin-resistant
Enterococcus (VRE), MDR Enterobacteriaceae, and MDR
glucose-non-fermenting gram-negative bacilli. Based on
the incidence and effect size found in our initial analysis,
we defined the primary exposure for subsequent analyses as
burn wound colonization with MDR Enterobacteriaceae.
Exposure groups were binary and defined as having MDR
Enterobacteriaceae colonization or not regardless of col-
onization with other MDR bacteria. The primary outcome
was in-hospital mortality.
Wound specimens were delivered to the laboratory
within 2 h of collection and plated to chocolate, colistin-
nalidixic acid, and MacConkey media, and incubated aer-
obically for up to 96 h at 37 C. Pathogens with [ 1?
growth were identified using bioMerieux API kits. Choice
of antibiotics tested for each organism was determined by
bacterial genus and based on the national list of medicines
available in Malawi. Enterobacteriaceae were routinely
tested for susceptibility against the following nine antibi-
otics: ampicillin, amoxicillin-clavulanic acid, cefotaxime,
ceftriaxone, imipenem, gentamicin, ciprofloxacin,
trimethoprim-sulfamethoxazole, and chloramphenicol by
standard Kirby Bauer disk diffusion methods according to
Clinical and Laboratory Standards Institute (CLSI) proto-
col [15].
Baseline characteristics of the study population are
described. Means are reported with standard deviations (±)
and medians with inter-quartile ranges (IQR). Patients who
were admitted to the hospital but missed a scheduled cul-
ture were included in the analysis. Bivariate analyses were
performed to examine the associations between those with
MDR Enterobacteriaceae colonization and baseline vari-
ables, as well as MDR Enterobacteriaceae colonization
and risk factors for inpatient mortality. The two-sample
t test was used for normal continuous variables, the Wil-
coxon rank-sum test for non-normal continuous variables,
and the Pearson Chi square test for categorical variables.
A log binomial model was used to estimate the risk ratio
for in-hospital mortality between those with and without
MDR Enterobacteriaceae colonization. After fitting the
initial model with in-hospital mortality and all potential
confounders, we used a change-in-effect method to remove
covariates that did not substantially contribute to the model
to estimate an adjusted risk ratio with 95% confidence
intervals.
All statistical analysis was performed using Stata/SE
13.1 (StataCorp LP, College Station, TX). The University
of North Carolina Institutional Review Board and the
Malawi National Health Services Review Committee
approved this study.
Results
During the study period, 100 patients were enrolled and 99
included in the analysis. One patient was not included in
the analysis as consent was revoked after initial enrollment.
Ninety-nine patients had an initial culture obtained. Eighty
patients were still admitted at the scheduled time of the
second culture of which seventy-seven (96%) had a culture
obtained. Forty-eight patients were admitted at the time of
their scheduled third culture with 46 patients (96%) having
a culture obtained.
Median age was 4 years (IQR 2–12), with a male pre-
ponderance at 53.5% (Table 1). Scald burns were the most
common at 61.6%, followed by flame burns at 37.4%, with
one patient having an electric burn. Most burns (52.5%)
were cooking related, and nearly 90% of patients presented
within 24 h. The median percent total body surface area
burn (%TBSA) was 14% (IQR 9–25). Among all patients,
20.2% had surgical intervention, such as burn excision and
skin grafting. The median length of stay was 15.5 days
(IQR 9–28). Fifty-four patients (55%) received antibiotics:
41 patients had antibiotics started on admission, and 13
patients were initiated on antibiotics after admission.
Among patients who received antibiotics, ceftriaxone was
used in 76% of patients.
Over the study period, the proportion of patients with
wound bacterial colonization increased substantially each
week. Bacterial colonization, excluding coagulase-negative
Staphylococcus, was present in 37% of patients on the first
culture and increased with each subsequent culture to 64
and 83%, respectively. (Fig. 1) The prevalence of MDR
bacteria also increased each week. MDR Enterobacteri-
aceae colonization was present in 8% of patients on the
first culture, in 28% on the second culture, and in 40% on
the third culture. Methicillin-resistant Staphylococcus
aureus (MRSA) colonization was similarly present for 12%
of patients on the first culture, for 28% on the second
culture, and for 39% on the third.
notably each week with over one-third of patients colo-
nized by their second week in the hospital. Most impor-
tantly, colonization with MDR Enterobacteriaceae was
associated with an 86% increased risk of mortality after
adjustment for significant covariates.
The sources of MDR bacteria in our unit were not elu-
cidated by this study but evidence suggests most patients
acquired their MDR bacteria in the hospital. Data over the
last few decades have demonstrated that hospitals, espe-
cially acute care tertiary facilities, are a common ‘‘breeding
ground’’ for antibiotic resistance [18]. The presence of
MDR bacteria is especially concerning for burn centers in
low-resource settings where overcrowding and limited
supplies make isolation nearly impossible, creating a haz-
ardous environment for the spread of infection and the
development of resistance in an immunocompromised
population. Evidence from the literature and our experi-
ence in Malawi also suggests several possibilities for
community-acquired colonization among the 10% of our
patients that presented to the hospital colonized with MDR
bacteria. The use of antibiotics in Malawi and in many
LMICs is largely unregulated leading to overuse of certain
classes [19]. There is also a dearth of clinicians available
for diagnosis and treatment, and when they are accessible
they have often have very limited diagnostic adjuncts for
managing infections [5, 19, 20].
Unfortunately, there is a paucity of data from sub-Sa-
haran Africa on the incidence of MDR bacterial coloniza-
tion and infection among burn patients. Limited evidence
from Nigeria, Ghana, and Malawi suggests that bacterial
antibiotic resistance is common among burn wound cul-
tures [21–24]. Several evaluations of burn wound micro-
biology in middle- or low-income countries outside of this
region have demonstrated similar findings [25–33]. How-
ever, from the published literature, the relationship
between burn wound colonization with MDR bacteria and
patient outcomes in LMICs is unclear. In high-income
countries, retrospective data has shown conflicting evi-
dence on the association between MDR bacterial colo-
nization or infection and hospital length of stay.
Furthermore, the literature is equivocal on the relationship
between MDR bacterial colonization and burn-associated
mortality [34, 35]. While our study did not show burn
wound colonization progressing to systemic infection, we
clearly demonstrated an association between MDR Enter-
obacteriaceae colonization and mortality after adjusting
for relevant confounders in our patient population.
Increased mortality may result from a failure to recognize
the progression from wound colonization to invasive dis-
ease or from inappropriate empirical antimicrobial therapy,
which can lead to eventual sepsis, multi-organ failure, and
death [36–38]. Given the limitations, our unit faces in the
prevention, diagnosis, and treatment of sepsis, the risk of
During their hospital course, 36% (36 of 99) patients 
developed MDR Enterobacteriaceae colonization.
(Table 1) Other than MRSA, which was detected in thirty-
three patients (33.3%), other MDR bacterial species were 
not common. No patients were colonized with VRE, and 
only 4 patients (4.0%) were colonized with MDR glucose-
non-fermenting gram negative bacilli. Among the 36 
patients colonized with MDR Enterobacteriaceae, the most 
common genera were Klebsiella (13 patients, 36%), Pro-
teus (13 patients, 36%), Enterobacter (7 patients, 19%) and 
Serratia (7 patients, 19%). Seven patients (19.4%) were 
colonized with more than one MDR Enterobacteriaceae 
species.
Table 1 compares characteristics of patients with and 
without MDR Enterobacteriaceae colonization. Notably, 
patients colonized with MDR Enterobacteriaceae had lar-
ger burns with a median TBSA of 18% (IQR 11–30) 
compared to 10% (IQR 7–20, p = 0.001). MDR Enter-
obacteriaceae colonization was more common in those 
with flame burns than scald burns (58.3 vs. 25.4%
(p = 0.004), and more patients with MDR Enterobacteri-
aceae colonization had surgery for their burn injury, 41.7%
compared to 7.9% (p \ 0.001). However, all but one 
patient had a positive culture for MDR Enterobacteriaceae 
prior to their first surgery. Patients with MDR Enterobac-
teriaceae colonization also had a longer length of stay than 
those without MDR Enterobacteriaceae colonization with 
a median of 27 days (IQR 18–49) versus 12 days (IRQ 
7–21), p \ 0.001.
Overall, crude in-hospital mortality was 19.2%, consis-
tent with previously published data from our patient pop-
ulation [16, 17]. Among those with MDR 
Enterobacteriaceae colonization, in-hospital crude mor-
tality was significantly higher at 36.1% compared to those 
without MDR Enterobacteriaceae colonization at 9.5%
(p = 0.001) (Table 2). The unadjusted risk ratio of death 
for those with MDR Enterobacteriaceae colonization 
compared to those without was 3.79 (CI 1.58, 9.11). When 
controlling for TBSA, burn type (scald vs. flame), sex, age, 
MRSA colonization, and length of stay, the adjusted risk 
ratio of death for patients with MDR Enterobacteriaceae 
colonization was 1.86 (CI 1.38, 2.50).
Discussion
Patients with burn wounds are frequently exposed to 
antimicrobial agents throughout their hospitalization, 
increasing the likelihood of colonization or infection with 
drug-resistant organisms. The presence of burn wound 
colonization with MDR Enterobacteriaceae was associated 
with an increasing TBSA, flame burns, and an increased 
length of stay. The prevalence of these bacteria increased
inadequately treating infection with MDR Enterobacteri-
aceae may be magnified in our patient population com-
pared to higher resource settings.
In order to adequately address this crisis, it is imperative
to identify specific practices that contribute to the devel-
opment of multidrug resistance and implement cost-effec-
tive strategies to address them. In the context of burn care,
substantial improvements are required in basic isolation
practices such as disposable dressings, cleaning supplies,
and sufficient hospital rooms to admit patients. In addition,
diagnostic resources are lacking in many institutions,
where even basic laboratory studies are not available,
making it very challenging to appropriately target antibi-
otic therapy to patient-specific infections. Evidence also
suggests that early excision of burn wounds significantly
reduces bacterial colonization and clinical wound infection
[39]. While we have shown that early excision is associated
with increased mortality in our patients, more aggressive
excision may play a role in an effort to control wound
infection [17]. Antibiotic stewardship is also important in
preventing resistance. Recommended strategies include
avoiding antibiotic prophylaxis for acute burn injury as
well as monitoring for appropriate use of antibiotics in both
the inpatient and outpatient settings [40]. Lastly, a need
exists to make additional classes of antibiotics available in
LMICs as well as to develop new antibiotics. In February
2017, the WHO issued an urgent call to develop new
antibiotics for twelve families of bacteria, including En-
terobacteriaceae in their critical category [41].
The strength of our study is its prospective methodology
and the quality of our laboratory. We are the only
prospective study to assess the microbiology of burn
wounds serially during hospitalization in sub-Saharan
Africa and the only study to our knowledge to examine the
association between MDR bacterial colonization and
mortality in LMICs. Our study is limited by a lack of blood
cultures and other diagnostic adjuncts such as basic labo-
ratory studies. However, given our resource constraints, it
was not possible to obtain these data for every patient. In
addition, we chose to use wound swabs for culture rather
than tissue biopsies due to feasibility and based on data that
have shown relative equivalence between the two
Table 1 Characteristics of all study patients with a subgroup
comparison of patients by colonization of multidrug-resistant
(MDR) Enterobacteriaceae. p values are based on subgroup bivariate
analysis using two-sample t test for normal continuous variables,
Wilcoxon rank-sum for non-normal continuous variables, and Pearson
Chi square test for categorical variables
All Patients (n = 99) Colonized with MDR
Enterobacteriaceae (n = 36)
Not colonized with MDR
Enterobacteriaceae (n = 63)
P value
Age (years)
Median (IQR) 4 (2–12) 5 (2–28) 3 (2–9) 0.06
Sex, n (%)
Male 53 (53.4) 23 (63.9) 30 (47.6) 0.1
Female 46 (46.6) 13 (36.1) 33 (52.4)
Burn type, n (%)
Scald 61 (61.6) 15 (41.7) 46 (73.0) 0.004
Flame 37 (37.4) 21 (58.3) 16 (25.4)
Electric 1 (1.0) 0 (0.0) 1 (1.6)
Cooking-related injury
n (%) 52 (52.5) 14 (38.9) 38 (60.3) 0.040
Presented within 24 h of injury
n (%) 86 (86.9) 30 (83.3) 56 (88.9) 0.5
Total body surface area burn (%)
Median (IQR) 14 (9–25) 18 (11–30) 10 (7–20) 0.001
Received surgical intervention for burn
n (%) 20 (20.2) 15 (41.7) 5 (7.9) \ 0.001
Received antibiotics
n (%) 54 (54.6) 22 (61.1) 32 (50.8) 0.3
Length of stay (days)
Median (IQR) 16 (9–28) 27 (18–49) 12 (7–21) \ 0.001
Colonized with methicillin-resistant Staphylococcus aureus
n (%) 33 (33.3) 17 (47.2) 16 (25.4) 0.027
colonization, improved isolation precautions, affordable
diagnostics, and antibiotic stewardship are imperative.
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Fig. 1 Changes in colonization with any bacterial species (excluding coagulase-negative Staphylococcus), multidrug-resistant Enterobac-
teriaceae, and methicillin-resistant Staphylococcus aureus comparing first, second, and third cultures
Table 2 In-hospital crude mortality based on multidrug-resistant (MDR) Enterobacteriaceae colonization with the unadjusted and adjusted risk
ratio of death for those patients with MDR Enterobacteriaceae colonization compared to those without
Colonized with MDR
Enterobacteriaceae (n = 36)
Not colonized with MDR
Enterobacteriaceae (n = 63)
P value
In-hospital crude mortality
N (%) 13 (36.1) 6 (9.5) 0.001
Unadjusted risk ratio of death 3.79 (CI 1.58, 9.11) 1.00 0.003
Adjusted risk ratio of death 1.86 (CI 1.38, 2.50) 1.00 \ 0.001
The adjusted risk ratio is adjusted for total body surface area, burn type (flame vs. scald), sex, age, length of stay, and methicillin-resistant
Staphylococcus aureus colonization
modalities [42]. While we were not able to show causality 
between positive wound cultures with MDR Enterobacte-
riaceae and the cause of death, we were able to adjust for 
relevant confounders in our model including risk factors 
for mortality in our patient population.
Conclusion
Our study demonstrates that among burn patients in an 
urban sub-Saharan African burn center, MDR bacterial 
wound colonization is very common, and MDR Enter-
obacteriaceae are associated with an increased risk of 
death. MDR bacteria are a critical global health issue, and 
an urgent response is required. In resource-poor environ-
ments, a greater emphasis on prevention of MDR bacterial
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